Malignancy ups risk of post-hysterectomy readmission

Malignancy ups risk of post-hysterectomy readmission
(HealthDay)—Risk factors have been identified for 30-day readmission following hysterectomy, according to a study published in the May issue of the American Journal of Obstetrics & Gynecology.

Malinda S. Lee, M.D., from Brigham and Women's Hospital/Massachusetts General Hospital in Boston, and colleagues examined risk factors for 30-day readmission following for 1,649 with nongravid hysterectomies conducted from 2008 through 2010 (1,009 for benign indications and 640 for malignancy).

The researchers found that 6 percent of the women were readmitted within 30 days, with a mean time to readmission of 13 days. For women undergoing hysterectomy with benign indications, the odds of readmission were increased with a history of a laparotomy (including cesarean delivery) (adjusted odds ratio [aOR], 2.12) and a perioperative complication (aOR, 2.41). For women undergoing hysterectomy for malignancy, the odds of readmission were increased with an American Society of Anesthesiologists Physical Status Classification of III or IV (aOR, 1.92), a longer length of initial hospitalization (three days: aOR, 7.83), and an estimated blood loss of >500 mL (aOR, 3.29); the risk of readmission was reduced for women who underwent a laparoscopic hysterectomy (aOR, 0.32) and for those who were discharged on postoperative day one (aOR, 0.16).

"These findings can serve to develop interventions to allow gynecologic surgeons to appropriately stratify patients at highest risk for at the time of hysterectomy," the authors write.


Explore further

Minimally invasive hysterectomy may be underused

More information: Abstract
Full Text (subscription or payment may be required)

Copyright © 2016 HealthDay. All rights reserved.

Citation: Malignancy ups risk of post-hysterectomy readmission (2016, May 9) retrieved 23 February 2019 from https://medicalxpress.com/news/2016-05-malignancy-ups-post-hysterectomy-readmission.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
3 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more